(Editors' note: This article contains graphic images of burn victims).
Business & Financial Update
Avita Medical Limited (OTCQX:AVMXY) reported total sales for the first half of the year 2014, ended December 31, 2013, of AUD $1.37 million (1 AUD = 0.92 USD). Total sales were up 1.3% from the same period ended December 21, 2012. However, sales of ReCell Spray-On-Skin™ were up 35% in the quarter compared to December 31, 2012 and up 11% for the six-month period ended December 31, 2013. Sales of ReCell grew nicely in the United Kingdom and Australia, up 52% and 29% for the quarter, respectively. Unit sales were up 34% in the UK, 17% in Germany, and 10% in Australia.
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|